Alpha 2.0
Login Register
» Authors » Geetha Shanmugam

Geetha Shanmugam

Explore the profile of Geetha Shanmugam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 179
Followers 0
Related Specialties
Oncology
Allergy & Immunology
Biology
Top 10 Co-Authors
Koustav Sarkar
Sudeshna Rakshit
Melvin George
Riasha Pal
Deep Bhattacharya
Nilanjan Paul
Nandana Jill
Oishi Mukherjee
Sannidhi Bhootra
Arunangsu Singh
Published In
Med Oncol
Nat Prod Res
Oral Oncol
Mol Biol Rep
Int Immunopharmacol
Affiliations
Soon will be listed here.
Recent Articles
11.
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients
Shanmugam G
Transpl Infect Dis . 2024 Jul; 26(4):e14341. PMID: 38980939
No abstract available.
12.
Letter to the editor, "Letter to the editor, "Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study."
Shanmugam G
Oral Oncol . 2024 Jul; 156:106935. PMID: 38968727
No abstract available.
13.
Antimicrobial peptides as novel anticancer agents: mechanistic insights and clinical prospects
Shanmugam G
Nat Prod Res . 2024 Jul; :1-2. PMID: 38954508
No abstract available.
14.
"Unlocking the potential of phytochemicals in cancer therapy"
Shanmugam G
Nat Prod Res . 2024 Jun; :1-3. PMID: 38919063
No abstract available.
15.
Letter to the editor, "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer."
Shanmugam G
Oral Oncol . 2024 Jun; 156:106915. PMID: 38917728
No abstract available.
16.
Letter to the editor, "Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma."
Shanmugam G
Oral Oncol . 2024 Jun; 155:106892. PMID: 38870592
No abstract available.
17.
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma
Roy S, Shanmugam G, Rakshit S, Pradeep R, George M, Sarkar K
Med Oncol . 2024 Apr; 41(5):115. PMID: 38622289
Bacopa monnieri (L) Wettst, commonly known as Brahmi, stands as a medicinal plant integral to India's traditional medical system, Ayurveda, where it is recognized as a "medhya rasayana"-a botanical entity...
18.
Wiskott Aldrich syndrome protein (WASp)-deficient Th1 cells promote R-loop-driven transcriptional insufficiency and transcription-coupled nucleotide excision repair factor (TC-NER)-driven genome-instability in the pathogenesis of T cell acute...
R P, Rakshit S, Shanmugam G, George M, Sarkar K
Clin Immunol . 2024 Apr; 263:110204. PMID: 38582251
Background: T-ALL is an aggressive hematological tumor that develops as the result of a multi-step oncogenic process which causes expansion of hematopoietic progenitors that are primed for T cell development...
19.
Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC)
Chandnani N, Mandal A, Gupta I, Mukherjee O, Rakshit S, Shanmugam G, et al.
Med Oncol . 2023 Dec; 41(1):28. PMID: 38146020
Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer which is the deadliest type of cancer for both men and women. Previous studies already showed that cell-intrinsic...
20.
Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies
R P, Shanmugam G, Rakshit S, Sarkar K
Pathol Res Pract . 2023 Dec; 253:155026. PMID: 38118219
As patients continue to suffer from lymphoproliferative and myeloproliferative diseases known as haematopoietic malignancies can affect the bone marrow, blood, lymph nodes, and lymphatic and non-lymphatic organs. Despite advances in...